The Combination of the Rexinoid, LG100268, and a Selective...

Clinical Cancer Research 2006 / 10 Vol. 12; Iss. 19

The Combination of the Rexinoid, LG100268, and a Selective Estrogen Receptor Modulator, Either Arzoxifene or Acolbifene, Synergizes in the Prevention and Treatment of Mammary Tumors in an Estrogen Receptor-Negative Model of Breast Cancer

Liby, K., Rendi, M., Suh, N., Royce, D. B., Risingsong, R., Williams, C. R., Lamph, W., Labrie, F., Krajewski, S., Xu, X., Kim, H., Brown, P., Sporn, M. B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-06-1119
Date:
October, 2006
File:
PDF, 476 KB
english, 2006
Conversion to is in progress
Conversion to is failed